Search
Confirm
Cancel
NEWS
News
>
News
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer
ProfoundBio
普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物(ADC)治疗窗口的新型药物连接子技术
普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物(ADC)治疗窗口的新型药物连接子技术
普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物(ADC)治疗窗口的新型药物连接子技术
Learn More +
普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物(ADC)治疗窗口的新型药物连接子技术
ProfoundBio Completed $55+ Million USD Series A Financing
ProfoundBio
ProfoundBio Completed $55+ Million USD Series A Financing普方生物宣布完成超过5500万美元的A轮融资
Learn More +
ProfoundBio Completed $55+ Million USD Series A Financing普方生物宣布完成超过5500万美元的A轮融资
Previous page
1
2

Contact us

Address:Suite 101&102, Bldg 1, P3A, 1 Xinze Street, SIP, Suzhou, China
E-mail:info@profoundbio.com

Copyright © 2021 ProfoundBio (Suzhou) Co., Ltd.   All rights reserved. 苏ICP备2021002620号 Powered by www.300.cn